logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Erythema Multiforme Severe

    FiltersReset Filters
    7 results

    • acthar

      (Repository Corticotropin)
      Mallinckrodt ARD LLC
      Usage: Acthar Gel is indicated for treating infantile spasms in infants, acute exacerbations of multiple sclerosis in adults, and various rheumatic disorders. It is also used for collagen diseases, severe dermatologic conditions, allergic states, specific ophthalmic and respiratory diseases, and to manage proteinuria in nephrotic syndrome.

    • depo-medrol

      (methylprednisolone acetate)
      Pharmacia & Upjohn Company LLC
      Usage: DEPO-MEDROL is indicated for severe allergic states, dermatoses, endocrine and gastrointestinal disorders, hematologic conditions, certain neoplasms, and respiratory diseases. It also treats nervous system issues, renal problems, and rheumatic diseases. Additionally, it can be administered intra-articularly for arthritis and intralesionally for specific dermatologic conditions.

    • depo-medrol

      (methylprednisolone acetate)
      Pharmacia & Upjohn Company LLC
      Usage: DEPO-MEDROL is indicated for various conditions, including severe allergic reactions, dermatologic diseases, endocrine and gastrointestinal disorders, hematologic issues, and certain rheumatic diseases. It is also used for cerebral edema, palliative care in neoplastic diseases, and localized therapies in dermatologic conditions via intralesional or intra-articular administration.

    • methylprednisolone acetate

      (Methylprednisolone acetate)
      Amneal Pharmaceuticals LLC
      Usage: Methylprednisolone acetate injectable suspension is indicated for intramuscular, intra-articular, and intralesional use to manage severe allergic reactions, dermatologic diseases, endocrine and gastrointestinal disorders, hematologic issues, neoplastic diseases, nervous system conditions, and various rheumatic and ophthalmic disorders.

    • methylprednisolone acetate

      (Methylprednisolone Acetate)
      Eugia US LLC
      Usage: Methylprednisolone acetate injectable suspension is indicated for intramuscular use in severe allergies, dermatologic, endocrine, gastrointestinal, hematologic, neoplastic, nervous system, ophthalmic, renal, respiratory, and rheumatic disorders. It is also used for intra-articular or soft tissue administration for specific joint conditions and intralesional administration for various localized dermatologic issues.

    • methylprednisolone sodium succinate

      (Methylprednisolone)
      Amneal Pharmaceuticals LLC
      Usage: Methylprednisolone sodium succinate is indicated for severe allergic conditions, dermatologic diseases, endocrine and gastrointestinal disorders, hematologic issues, and specific neurological, ophthalmic, renal, respiratory, and rheumatic disorders. It is used when oral therapy is not feasible, particularly in acute or critical situations.

    • rayos

      (prednisone)
      Horizon Therapeutics USA, Inc.
      Usage: RAYOS is indicated for severe allergic conditions, various dermatologic and endocrine diseases, gastrointestinal disorders (like Crohn's and ulcerative colitis), hematologic issues, neoplasms, nervous system conditions (such as multiple sclerosis), certain ophthalmic diseases, organ transplant rejection, pulmonary disorders, renal conditions, rheumatologic ailments, and specific infectious diseases.